Sessa, C <br/><br/>
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  May 2009 
 - 1153-1161 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2008.11.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alanine Transaminase--metabolism<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics<br/>Aspartate Aminotransferases--metabolism<br/>Breast Neoplasms--drug therapy<br/>Dioxoles--adverse effects<br/>Doxorubicin--adverse effects<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Liver--drug effects<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neutropenia--chemically induced<br/>Sarcoma--drug therapy<br/>Tetrahydroisoquinolines--adverse effects<br/>Trabectedin<br/>Treatment Outcome<br/>Vomiting--chemically induced